Plexa ProMRI
Device Cardiology/Vascular Diseases
PDI 04035479140014
General payments
$228,399
Research payments
$2,083,908
Through program year 2025, $228,399 in general payments and $2,083,908 in research payments were reported against Plexa ProMRI (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $612 | 19 |
| 2025 | Research | $167,290 | 99 |
| 2024 | General | $115,082 | 52 |
| 2024 | Research | $438,913 | 1,712 |
| 2023 | General | $107,175 | 172 |
| 2023 | Research | $729,736 | 3,785 |
| 2022 | General | $5,530 | 50 |
| 2022 | Research | $739,270 | 5,472 |
| 2021 | Research | $8,698 | 4 |
Breakdown
The top 5 of 18 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
293 general · 11,072 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.